Literature DB >> 29352688

The Association Between Readmission and Patient Experience in a Total Hip Arthroplasty Population.

.   

Abstract

BACKGROUND: Our goal was to determine whether readmissions within 30 or 90 days following discharge are associated with Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores for total hip arthroplasty (THA) patients.
METHODS: HCAHPS surveys from all patients who underwent THA between January 2016 and September 2016 in our institution were analyzed. Readmissions, demographics, baseline joint pain, joint function, and Veterans RAND-12 scores were collected. Statistical analyses involved Pearson's chi-squared tests for categorical variables and Student's t-tests for continuous variables. Multivariable logistic regression models were used to determine whether 30-day or 90-day readmissions were independently associated with HCAHPS scores.
RESULTS: A total of 1868 patients were identified, the survey was sent to 969 patients and 578 completed the survey (59.6%). Eight patients (1.4%) were readmitted within 30 days, and 28 patients (4.8%) within 90 days. These patients were more likely to undergo revision THA (P < .001). For the 30-day readmission cohort, 4 of 8 patients (50.0%) rated the hospital a 9 or 10 out of 10 compared to 466 of 567 patients (82.2%) of the non-readmitted cohort (P = .019). Thirty-day readmissions were associated with significantly lower likelihood of rating the hospital a 9 or 10 out of 10 (odds ratio 0.18).
CONCLUSIONS: Our results demonstrate a significant negative association between readmission and HCAHPS scores under several dimensions of the survey including nurse communication, doctor communication, pain management, and global satisfaction with the hospital experience.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  30-day; 90-day; Press Ganey; patient satisfaction; readmission; total hip arthroplasty

Mesh:

Year:  2017        PMID: 29352688     DOI: 10.1016/j.arth.2017.12.023

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  7 in total

1.  ASSOCIATION RULES IN HEART FAILURE READMISSION RATES AND PATIENT EXPERIENCE SCORES.

Authors:  Braden Tabisula
Journal:  Perspect Health Inf Manag       Date:  2021-07-01

2.  Effectiveness of a Web-Based Electronic Prospective Data Collection Tool for Surgical Data in Shoulder Arthroplasty.

Authors:  Sambit Sahoo; José A Rodríguez; Matthew Serna; Kurt P Spindler; Kathleen A Derwin; Joseph P Iannotti; Eric T Ricchetti
Journal:  Semin Arthroplasty       Date:  2021-02-13

3.  Validity and efficiency of a smartphone-based electronic data collection tool for operative data in rotator cuff repair.

Authors:  Sambit Sahoo; Jill Mohr; Gregory J Strnad; Jose Vega; Morgan Jones; Mark S Schickendantz; Lutul Farrow; Kurt P Spindler; Joseph P Iannotti; Eric T Ricchetti; Kathleen A Derwin
Journal:  J Shoulder Elbow Surg       Date:  2019-05-02       Impact factor: 3.019

4.  Risk Factors for Readmission After Knee Arthroplasty Based on Predictive Models: A Systematic Review.

Authors:  Satish M Mahajan; Chantal Nguyen; Justin Bui; Enomwoyi Kunde; Bruce T Abbott; Amey S Mahajan
Journal:  Arthroplast Today       Date:  2020-06-17

5.  High prevalence and seasonal variation of hypovitaminosis D in patients scheduled for lower extremity total joint arthroplasty.

Authors:  Nicolas S Piuzzi; Jaiben George; Anton Khlopas; Alison K Klika; Michael A Mont; George F Muschler; Carlos A Higuera
Journal:  Ann Transl Med       Date:  2018-08

6.  Patient-related Factors and Perioperative Outcomes Are Associated with Self-Reported Hospital Rating after Spine Surgery.

Authors:  Elbert J Mets; Michael R Mercier; Ari S Hilibrand; Michelle C Scott; Arya G Varthi; Jonathan N Grauer
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

7.  Public Hospitals in China: Is There a Variation in Patient Experience with Inpatient Care.

Authors:  Wenhua Wang; Ekaterina Katya Loban; Emilie Dionne
Journal:  Int J Environ Res Public Health       Date:  2019-01-11       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.